Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala.

The Journal of comparative neurology | 2009

Activation of neuropeptide Y (NPY) Y1 receptors (Y1r) in the rat basolateral nuclear complex of the amygdala (BLA) produces anxiolysis and interferes with the generation of conditioned fear. NPY is important in regulating the output of the BLA, yet the cell types involved in mediating this response are currently unknown. The current studies employed multiple label immunocytochemistry to determine the distribution of Y1r-immunoreactivity (-ir) in glutamatergic pyramidal and GABAergic cell populations in the BLA using scanning laser confocal stereology. Pyramidal neurons were identified by expression of calcium-calmodulin dependent kinase II (CaMKII-ir) and functionally distinct interneuron subpopulations were distinguished by peptide (cholecystokinin, somatostatin) or calcium-binding protein (parvalbumin, calretinin) content. Throughout the BLA, Y1r-ir was predominately on soma with negligible fiber staining. The high degree of coexpression of Y1r-ir (99.9%) in CaMKII-ir cells suggests that these receptors colocalize on pyramidal cells and that NPY could influence BLA output by directly regulating the activity of these projection neurons. Additionally, Y1r-ir was also colocalized with the interneuronal markers studied. Parvalbumin-ir interneurons, which participate in feedforward inhibition of BLA pyramidal cells, represented the largest number of Y1r expressing interneurons in the BLA ( approximately 4% of the total neuronal population). The anatomical localization of NPY receptors on different cell populations within the BLA provides a testable circuit whereby NPY could modulate the activity of the BLA via actions on both projection cells and interneuronal cell populations.

Pubmed ID: 19731317 RIS Download

Associated grants

  • Agency: NIMH NIH HHS, United States
    Id: R01 MH062621
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH062621-04
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH062621-05
  • Agency: NIMH NIH HHS, United States
    Id: MH62621

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Calretinin antibody (antibody)

RRID:AB_10000321

This polyclonal targets calretinin

View all literature mentions

Monoclonal anti Parvalbumin (antibody)

RRID:AB_10000343

This monoclonal targets parvalbumin

View all literature mentions

Goat anti-parvalbumin (antibody)

RRID:AB_10000345

This polyclonal targets parvalbumin

View all literature mentions

Anti-CaMKII, clone 6G9 (antibody)

RRID:AB_2067919

This monoclonal targets Camk2a

View all literature mentions

cholecystokinin (antibody)

RRID:AB_2314185

This unknown targets

View all literature mentions

Somatostatin (antibody)

RRID:AB_2315346

This unknown targets

View all literature mentions

Y1r (antibody)

RRID:AB_2315613

This unknown targets

View all literature mentions